Results 51 to 60 of about 11,159 (187)
Genome-wide screening of micafungin-sensitive mutants.
, 2013 (A) Summary of micafungin-sensitive mutants screening. (B) Representative examples of isolated mutants that showed varying levels of sensitivity to micafungin.
Yuki Yamada (104430) +6 more
core +1 more source
Mycoses, Volume 69, Issue 9, September 2026.ABSTRACT Background Opportunistic yeasts account for a substantial proportion of invasive fungal infections and are important agents of healthcare‐associated infections, especially in intensive care units (ICUs). Objectives To describe the clinical and epidemiological characteristics of hospitalized patients with positive cultures for medically ...
Yasmim Passos Lima +8 more
wiley +1 more source
Mycoses, Volume 69, Issue 9, September 2026.ABSTRACT Objective To initially evaluate the feasibility and potential clinical value of high‐resolution computed tomography (HRCT)‐based three‐dimensional (3D) airway reconstruction combined with computational spray simulation for guiding bronchoscopic amphotericin B delivery in patients with chronic pulmonary aspergillosis (CPA).
Yonghui Cheng +9 more
wiley +1 more source
Clinical efficacy and safety of micafungin, a novel echinocandin antifungal drug, in pulmonary aspergillosis in a postmarketing setting [PDF]
, 2010 今回われわれは，呼吸器領域で実施された市販後調査の成績をもとに，慢性肺アスペルギルス症（chronic pulmonary aspergillosis：CPA）に対するmicafungin（MCFG）の有効性および安全性を検討した。 35施設から収集された109例のうち，CPAの診断が確認できなかった症例や併用薬の規定に違反した症例計18例を除く91例を有効性解析対象例とした。このうち，評価不能であった11例を除く80例の有効率は63.8％（51/80例）であった ...
網谷, 良一 +7 more
core
Peer review of the pesticide risk assessment of the active substance Beauveria bassiana strain R444
EFSA Journal, Volume 24, Issue 9, September 2026.Abstract The conclusions of the EFSA following the peer review of the initial risk assessments carried out by the competent authority of the rapporteur Member State, Denmark, for the pesticide active substance Beauveria bassiana strain R444 and the considerations as regards the inclusion of the substance in Annex IV of Regulation (EC) No 396/2005 are ...
European Food Safety Authority (EFSA) +47 more
wiley +1 more source
Frontiers in Microbiology, 2020 Pseudomonas aeruginosa and Candida spp. are biofilm-forming pathogens commonly found colonizing medical devices, being mainly associated with pneumonia and bloodstream infections.
Luciana Fernandes +3 more
doaj +1 more source
Practices of Antifungal Prophylaxis Among Italian Pediatric Oncology–Hematology Centers
eJHaem, Volume 7, Issue 4, August 2026.ABSTRACT Background IFD is a significant cause of illness and death among pediatric patients undergoing chemotherapy or HSCT. Application of AFP in children varies widely and is frequently off‐label. This survey aims to describe real‐world AFP practices across centers within AIEOP and provide an estimate of IFD incidence.
Martina Colli +23 more
wiley +1 more source
MicrobiologyOpen, Volume 15, Issue 4, August 2026.This study explores new antifungal strategies to combat non‐albicans Candida species. We tested clinically approved HDAC inhibitors—Vorinostat, Romidepsin, Tucidinostat—and the HDAC6/8‐selective MC1568, alone and with Fluconazole. The Fluconazole/MC1568 combination significantly enhanced antifungal activity and reduced biofilm formation.
Andrea Giammarino +10 more
wiley +1 more source
Long‐Term Use of Rezafungin: A Case Report and Insights Into Real‐World Access
Transplant Infectious Disease, EarlyView.
Jian Mei Li +2 more
wiley +1 more source
From Oral Candidiasis to Candidemia: A Review of Superficial to Invasive Progression
MicrobiologyOpen, Volume 15, Issue 4, August 2026.Recent and limited evidence indicates that oral candidiasis can disseminate Candida albicans throughout the body, leading to invasive candidiasis, such as candidemia, a life‐threatening infection. Considering antifungal resistance and global outbreaks of emergent non‐albicans Candida and related yeasts, murine models help understand dissemination ...
Julia Robledo Jerez +3 more
wiley +1 more source